DISSOLUTION TIME, ON RECONSTITUTION, OF A NEW PARENTERAL FORMULATION OF DOXORUBICIN (DOXORUBICIN RAPID DISSOLUTION)

被引：4
|
作者：
MURPHY, A
MALTBY, S
LAUNCHBURY, AP
机构：
[1] FARMITALIA CARLO ERBA LTD,ST ALBANS AL1 3AW,ENGLAND
[2] BELVOIR PK HOSP,BELFAST,NORTH IRELAND
[3] ROYAL MARSDEN HOSP,LONDON,ENGLAND
来源：
INTERNATIONAL JOURNAL OF PHARMACEUTICS | 1987年 / 38卷 / 1-3期
关键词：
D O I：
10.1016/0378-5173(87)90124-4
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：257 / 259
页数：3
相关论文
共 50 条
  • [31] Quantitative Cryo-TEM Reveals New Structural Details of Doxil-Like PEGylated Liposomal Doxorubicin Formulation
    Nordstrom, Rickard
    Zhu, Lin
    Harmark, Johan
    Levi-Kalisman, Yael
    Koren, Erez
    Barenholz, Yechezkel
    Levinton, Genia
    Shamrakov, Dima
    PHARMACEUTICS, 2021, 13 (01) : 1 - 19
  • [32] Improved Dissolution Time and Oral Bioavailability of Pioglitazone Using Liquisolid Tablets: Formulation, In Vitro Characterization, and In Vivo Pharmacokinetics in Rabbits
    Swain, Ranjit Prasad
    Elhassan, Gamal Osman
    Bhattacharjee, Abhishek
    Sahu, Ram Kumar
    Khan, Jiyauddin
    ACS OMEGA, 2024, 9 (42): : 42687 - 42697
  • [33] Regulatory Experience with Continuous Manufacturing and Real Time Release Testing for Dissolution in New Drug Applications
    Kakhi, Maziar
    Li, Jing
    Dorantes, Angelica
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 112 (10) : 2604 - 2614
  • [34] Phase I and pharmacokinetic (PK) study of a new liposome-encapsulated doxorubicin formulation in patients with refractory solid tumors.
    Muñoz, C
    Muñoz, M
    Balaña, C
    Pontón, JL
    Garcia, M
    Llorens, MA
    GImeno, M
    Rosell, R
    Germá, JR
    Izquierdo, MA
    ANNALS OF ONCOLOGY, 2000, 11 : 134 - 135
  • [35] New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: Part I - Formulation development and in-vitro characterization
    Tinkov, Steliyan
    Winter, Gerhard
    Coester, Conrad
    Bekeredjian, Raffi
    JOURNAL OF CONTROLLED RELEASE, 2010, 143 (01) : 143 - 150
  • [36] Disintegration Rate and Properties of Active Pharmaceutical Ingredient Particles as Determined from the Dissolution Time Profile of a Pharmaceutical Formulation: An Inverse Problem
    Horkovics-Kovats, Stefan
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 103 (02) : 456 - 464
  • [37] Monitoring the dissolution of active pharmaceutical ingredient and TPGS in real time via IR spectroscopy during the manufacturing of liquid dosage formulation
    Sasic, Slobodan
    Palm, Andrew S.
    Tang, Degui
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2012, 70 : 273 - 279
  • [38] Simple and rapid monitoring of doxorubicin using streptavidin-modified microparticle-based time-resolved fluorescence immunoassay
    Liang, Junyu
    Zhang, Zhigao
    Zhao, Hui
    Wan, Shanhe
    Zhai, Xiangming
    Zhou, Jianwei
    Liang, Rongliang
    Deng, Qiaoting
    Wu, Yingsong
    Lin, Guanfeng
    RSC ADVANCES, 2018, 8 (28) : 15621 - 15631
  • [39] Simulating Different Dosing Scenarios for a Child-Appropriate Valproate ER Formulation in a New Pediatric Two-Stage Dissolution Model
    Frank Karkossa
    Antonia Krueger
    Jana Urbaniak
    Sandra Klein
    AAPS PharmSciTech, 2017, 18 : 309 - 316
  • [40] Simulating Different Dosing Scenarios for a Child-Appropriate Valproate ER Formulation in a New Pediatric Two-Stage Dissolution Model
    Karkossa, Frank
    Krueger, Antonia
    Urbaniak, Jana
    Klein, Sandra
    AAPS PHARMSCITECH, 2017, 18 (02): : 309 - 316
12345